Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anjan K Chakrabarti

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
The Journal of Invasive Cardiology|December 8, 2011
The SYNTAX score: usefulness, limitations, and future directionsAnjan K Chakrabarti, C Michael Gibson
Evidence-Based Medicine|September 23, 2011
Short- and long-term treatment with non-steroidal anti-inflammatory drugs increases risk of death or recurrent MI in those with previous MIAnjan K Chakrabarti, C Michael Gibson
Evidence-Based Medicine|January 24, 2014
Percutaneous coronary intervention of culprit and non-culprit coronary arteries in acute ST-elevation MI may improve outcomesStuart H Chen, Anjan K Chakrabarti
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|September 18, 2013
Optimizing reperfusion in patients with STEMI: a critical evaluation of pharmacologic and non-pharmacologic strategiesXiaoyu Yang, Duane S Pinto, Anjan K Chakrabarti
Current Opinion in Cardiology|October 4, 2012
Optimal selection of STEMI treatment strategies in the current era: benefit of transferring STEMI patients for PCI compared with administration of onsite fibrinolytic therapyAnjan K Chakrabarti, C Michael Gibson, Duane S Pinto
Future Cardiology|February 18, 2021
Door-to-unload: left ventricular unloading before reperfusion in ST-elevation myocardial infarctionMalav J Parikh, Karl H Schuleri, Anjan K Chakrabarti, et al.
Cardiology Research and Practice|July 26, 2012
Admission hyperglycemia and acute myocardial infarction: outcomes and potential therapies for diabetics and nondiabeticsAnjan K Chakrabarti, Priyamvada Singh, Lakshmi Gopalakrishnan, et al.
Journal of Atrial Fibrillation|May 13, 2017
Cost-Effective Medicines for Stroke Prophylaxis in Patients with Atrial FibrillationAnjan K Chakrabarti, Shalin J Patel, Payal Kohli, et al.
Interventional Cardiology Clinics|June 6, 2017
Newer Pharmaceutical Agents for STEMI InterventionsAnjan K Chakrabarti, Shalin J Patel, Robert L Salazar, et al.
Vascular Medicine (London, England)|March 3, 2004
Interactive effects of the ACE DD polymorphism with the NOS III homozygous G849T (Glu298-->Asp) variant in determining endothelial function in coronary artery diseaseMichael A Schmidt, Anjan K Chakrabarti, Chris Kehrer, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
The Journal of Invasive Cardiology|December 8, 2011
The SYNTAX score: usefulness, limitations, and future directionsAnjan K Chakrabarti, C Michael Gibson
Evidence-Based Medicine|September 23, 2011
Short- and long-term treatment with non-steroidal anti-inflammatory drugs increases risk of death or recurrent MI in those with previous MIAnjan K Chakrabarti, C Michael Gibson
Evidence-Based Medicine|January 24, 2014
Percutaneous coronary intervention of culprit and non-culprit coronary arteries in acute ST-elevation MI may improve outcomesStuart H Chen, Anjan K Chakrabarti
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|September 18, 2013
Optimizing reperfusion in patients with STEMI: a critical evaluation of pharmacologic and non-pharmacologic strategiesXiaoyu Yang, Duane S Pinto, Anjan K Chakrabarti
Current Opinion in Cardiology|October 4, 2012
Optimal selection of STEMI treatment strategies in the current era: benefit of transferring STEMI patients for PCI compared with administration of onsite fibrinolytic therapyAnjan K Chakrabarti, C Michael Gibson, Duane S Pinto
Future Cardiology|February 18, 2021
Door-to-unload: left ventricular unloading before reperfusion in ST-elevation myocardial infarctionMalav J Parikh, Karl H Schuleri, Anjan K Chakrabarti, et al.
Cardiology Research and Practice|July 26, 2012
Admission hyperglycemia and acute myocardial infarction: outcomes and potential therapies for diabetics and nondiabeticsAnjan K Chakrabarti, Priyamvada Singh, Lakshmi Gopalakrishnan, et al.
Journal of Atrial Fibrillation|May 13, 2017
Cost-Effective Medicines for Stroke Prophylaxis in Patients with Atrial FibrillationAnjan K Chakrabarti, Shalin J Patel, Payal Kohli, et al.
Interventional Cardiology Clinics|June 6, 2017
Newer Pharmaceutical Agents for STEMI InterventionsAnjan K Chakrabarti, Shalin J Patel, Robert L Salazar, et al.
Vascular Medicine (London, England)|March 3, 2004
Interactive effects of the ACE DD polymorphism with the NOS III homozygous G849T (Glu298-->Asp) variant in determining endothelial function in coronary artery diseaseMichael A Schmidt, Anjan K Chakrabarti, Chris Kehrer, et al.
Pageof 2